Tylenol and Autism: More to the Story

 Joan Swirsky discusses the increasing rates of autism in children and explores the possible connection between prenatal Tylenol (acetaminophen) use and autism, as well as highlighting the role of ultrasound examinations during pregnancy as a potential factor in rising autism rates.

1. Increasing Autism Rates: The article begins by stating that in 2020, the CDC estimated one in 36 children had autism, which surged to one in 31 by 2025, attributing this rise partially to the use of Tylenol by pregnant women.

2. FDA Awareness: It is mentioned that the FDA was aware of the potential link between Tylenol and autism over fifteen years ago but did not take action, raising concerns about financial interests influencing health decisions in the medical industry.

3. Lawsuits Against Acetaminophen: Since September 2022, more than 100 lawsuits have been initiated against acetaminophen manufacturers, claiming they failed to warn about the risks of autism and ADHD related to its use during pregnancy.

4. Ultrasounds as a Potential Cause: The author shares her personal experience in obstetrics and notes the significant increase in ultrasound usage, suggesting a possible correlation between high numbers of ultrasounds during pregnancy and rising autism rates.

5. Global Trends: The article references studies indicating the increasing autism rates are a global phenomenon, with more pronounced effects in countries that use routine prenatal ultrasound.

6. Sonar Effects on Marine Life: The author draws parallels between the effects of sonar on marine life, noting that sound waves can cause mass deaths in dolphins and questioning the effects of ultrasound on developing human fetuses.

7. Health Concerns of Ultrasound: Studies since the 1980s have suggested potential neurological effects from ultrasound exposure, yet in 1993, the FDA allowed the output of ultrasound equipment to increase significantly without considering fetal health.

8. Research Findings: Studies, including one from Yale, suggest that prenatal ultrasound may lead to brain damage in offspring, which could explain increasing rates of autism and other neurological disorders.

9. Financial Interests: The article raises concerns about the financial incentives behind prenatal ultrasound technology, suggesting that the medical industry may be prioritizing profits over fetal health.

10. Call to Action: The author urges for more research and caution regarding ultrasound exposure during pregnancy and emphasizes the need for awareness similar to the warnings about Tylenol.

Joan Swirsky argues that while Tylenol's link to autism is receiving attention, the effects of prenatal ultrasound usage—another potential contributor to rising autism rates—are being ignored. She calls for a reevaluation of the safety and practices surrounding prenatal ultrasound to protect the health of future generations.

https://www.americanthinker.com/articles/2025/10/tylenol_and_autism_more_to_the_story.html